Clinical Trials Directory

Trials / Completed

CompletedNCT05770921

Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia(PSVT)

An Exploratory Study of Pulsed Field Ablation Device and Force Sensing Pulsed Field Ablation Catheter Guided by Columbus 3D EP Navigation System in the Ablation Treatment of Paroxysmal Supraventricular Tachycardia(PSVT)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Ningbo No. 1 Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study was to explore the safety and efficacy of a Pulsed Field Ablation Device and Force Sensing Pulsed Field Ablation Catheter in the treatment of Paroxysmal Supraventricular Tachycardia.

Detailed description

The Primary Endpoint for efficacy is the number of subjects where ablation of each PSVT resulted in confirmation of electrical isolation of the PSVT 15 minutes following the last index PFA application with the investigational device

Conditions

Interventions

TypeNameDescription
DEVICEPulsed Field Ablation Device and Force Sensing Pulsed Field Ablation CatheterAll subjects will be ablated using the Pulsed Field Ablation Device and Force Sensing Pulsed Field Ablation Catheter in the management of their Paroxysmal Supraventricular Tachycardia

Timeline

Start date
2022-10-11
Primary completion
2023-02-01
Completion
2023-07-13
First posted
2023-03-16
Last updated
2024-01-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05770921. Inclusion in this directory is not an endorsement.